PHL Treatment in Pancreatic Cancer

Clinical trial NCT05365893 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05365893
Sponsor: Fox Chase Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma

Start date: 2021-10-20
Primary completion: 2025-12-18
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.